Long-term drug survival of dupilumab and associated predictors in moderate-to-severe atopic dermatitis: A real-world prospective cohort study.

Subjects

Subjects :

Humans
Prospective Studies
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal
Treatment Outcome
Severity of Illness Index
Dermatitis, Atopic drug therapy

Details

Language :

English

ISSN :

1468-3083

Volume :

37

Issue :

6

Database :

MEDLINE

Journal :

Journal of the European Academy of Dermatology and Venereology : JEADV

Publication Type :

Editorial & Opinion

Accession number :

36662631

Full Text :

https://doi.org/10.1111/jdv.18889